Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 35.0B | 49.0B | 41.1B | 39.0B |
| Cost of revenue | 29.1B | 37.6B | 31.1B | 31.5B |
| Gross profit | 5.9B | 11.4B | 10.0B | 7.5B |
| Operating expense | ||||
| Research & development | 345.9M | 324.3M | 384.6M | 443.8M |
| Selling general and admin | 3.2B | 5.8B | 3.3B | 2.7B |
| Other operating expenses | — | — | — | — |
| Operating income | 2.3B | 5.3B | 6.3B | 4.3B |
| Non operating interest income | ||||
| Income | 1.4B | 1.6B | 1.5B | 1.4B |
| Expense | 1.4B | 1.4B | 1.5B | 1.4B |
| Other income expense | — | — | — | — |
| Pretax income | 1.9B | 7.5B | 6.5B | 5.5B |
| Tax provision | 1.1B | 2.3B | 1.9B | 2.0B |
| Net income | 768.4M | 5.3B | 4.6B | 3.5B |
| Basic EPS | 0.1 | — | 0.4 | 0.3 |
| Diluted EPS | 0.1 | — | 0.4 | 0.3 |
| Basic average shares | 7.5B | — | 7.5B | 9.1B |
| Diluted average shares | 7.5B | — | 7.7B | 9.1B |
| EBITDA | 7.5B | 14.8B | 13.2B | 10.4B |
| Net income from continuing op. | 1.9B | 7.5B | 6.5B | 5.5B |
| Minority interests | -241.1M | -1.4B | -1.5B | -1.2B |
| Preferred stock dividends | 0 | 0 | 0 | 0 |